The Gastric Cancer Foundation: A Gastric Cancer Registry
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01514045 |
Recruitment Status
:
Recruiting
First Posted
: January 20, 2012
Last Update Posted
: April 3, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Gastric Cancer |
Study Type : | Observational |
Estimated Enrollment : | 500 participants |
Observational Model: | Ecologic or Community |
Time Perspective: | Cross-Sectional |
Official Title: | The Gastric Cancer Foundation: A Gastric Cancer Registry |
Study Start Date : | April 2011 |
Estimated Primary Completion Date : | December 2020 |
Estimated Study Completion Date : | December 2021 |

- Collect detailed clinical and epidemiological information on patients with gastric cancer; with a family history of gastric cancer in a first or second degree relative; or persons with a known germline mutation in their CDH1 (E-Cadherin) gene [ Time Frame: 1 day ]
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients are eligible if they have a histologically proven gastric tumor including gastroesophageal tumors; OR they have a family history of gastric cancer in a first or second degree relative; OR persons with a known germline mutation in their CDH1 (E-Cadherin) gene.
- 18 years of age or older
- Adequate English proficiency to complete online consent and questionnaire.
Exclusion Criteria:
- Under 18 years of age
- No history of gastric cancer or gastric cancer in a family member or a known germline mutation in their CDH1 gene.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01514045
Contact: Alison Almeda | 650-497-3619 | aalmeda@stanford.edu |
United States, California | |
Stanford University, School of Medicine | Recruiting |
Stanford, California, United States, 94305 | |
Contact: Alison Almeda 650-497-3619 aalmeda@stanford.edu | |
Principal Investigator: James M Ford, MD | |
Sub-Investigator: Hanlee P Ji, MD |
Principal Investigator: | James M Ford, MD | Stanford University |
Responsible Party: | Stanford University |
ClinicalTrials.gov Identifier: | NCT01514045 History of Changes |
Other Study ID Numbers: |
GI0005 SU-01172012-8987 ( Other Identifier: Stanford University ) 20285 ( Other Identifier: Stanford University ) |
First Posted: | January 20, 2012 Key Record Dates |
Last Update Posted: | April 3, 2018 |
Last Verified: | March 2018 |
Keywords provided by Stanford University:
Quality of Life |
Additional relevant MeSH terms:
Stomach Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site |
Neoplasms Digestive System Diseases Gastrointestinal Diseases Stomach Diseases |